Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Teriflunomide for the treatment of multiple sclerosis.
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran.
Quantitative Susceptibility Mapping in Multiple Sclerosis.
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.
Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses.
Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?
[Consensus document on spasticity in patients with multiple sclerosis.]
Organic Causes of Erectile Dysfunction in Men Under 40.
Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
Clinical data and regulatory issues of biosimilar products.
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
The over time development of chronic illness self-management patterns: a longitudinal qualitative study.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
Efficacy of lower fingolimod doses in the treatment of MS.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis.
Pages
« first
‹ previous
…
358
359
360
361
362
363
364
365
366
…
next ›
last »